<unk>  is a monoamine oxidase type B (MAO-B) inhibitor that is FDA approved for the adjunctive treatment of levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off" episodes.   Common adverse reactions include dyskinesia, fall, nausea, and insomnia.
Safinamide
Pyrazinamide
Ethambutol
Isoniazid 
Rifampin 
Rifampin isoniazid
Micronomicin
Monoxerutin